Advertisement
Screener

Benitec Biopharma Inc. (BNTC) Patents: Active

Benitec Biopharma Inc. Active Patents

1 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2021-09-01: Application 17463923; Invention Reagents for Treatment of Oculopharyngeal Muscular Dystrophy (OPMD) and Use Thereof; Applicant Benitec IP Holdings, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2021-09-0117463923Reagents for Treatment of Oculopharyngeal Muscular Dystrophy (OPMD) and Use ThereofBenitec IP Holdings, Inc.Patented Case2024-03-1911932852US20220056446A1
Vanessa Strings-Ufombah
David Suhy
United States
United States
WHITEMAN, BRIAN A

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Vogenx, Inc. (VOGX)United States$0.355B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58